Not really sir
All the best
Godsown
1 Like
What about genotype E? @availlant
A total cure will never come out. They spend billions on pointless wars and projects but cant they cant fund for a total cure. To keep you a bit hopefull they say āmaybe a functional cure will come outā
Medical field got hijacked by powerfull people.
This world is cruel and they dont give a **** about you or me. Were in the darkness
2 Likes
Hi @H020,
Again, I appreciate the passion you have for this issue and it is definitely frustrating as someone with hepatitis B to see so much being spent on other things that appear pointless.
However, your blanket statements do neglect a lot of the sincere and selfless efforts in the field (in academia, industry, policy and other places) to try to tackle these issues. Yes, they may be in the minority and are struggling to move the needle, but almost all big change starts off this way.
I hope itās clear that I do give a shit, and want to build a community that will help others do the same and come together to drive changes. It is completely up to you whether you want to be part of that or not, but I sincerely hope you do.
Thomas
11 Likes
God speed to you Dr Thomas
3 Likes
I want to echo Thomasā annoyance with this kind of commentary from @H020. It is simply not productive, not accurate and ignorant of the countless hours of work that numerous labs from around the world are spending to try to help patients.
I also want to point that these kinds of posts are also quite disrespectful of the time, effort and commitment that Thomas puts into this forum., which otherwise would not exist.
7 Likes
Completely agree! so grateful to all the researchers and specialists working towards this extremely difficult task of finding a cure. Very thankful to @ThomasTu @availlant and others for the valuable time and information that they provide on this forum.
1 Like
Thanks so much for the time, effort everything.Till when are the patients going to get the cure?
Hi @availlant,
Hi Andrew! I and I am sure others were starting to get a little worried about you! Hope you are doing well and are just busy. Glad to have you back if you are back.
-Paul
I think that badly put comment was directed at the big guys, like the FDA, who imho have shown some bias and corruptionā¦ especially over COVID
Certainly I canāt imagine it would be directed at the excellent people here who have been doing amazing work at actually making a cure for this thing (and doing extra work on top of that by making this community/posting to it and engaging with us)
In any case Iād like to thank you guys. Without your work, and without your communication, things would be far worse. So yāall mean a lot to me. Thank you truly
3 Likes
Hi @PuallyHBV ,
I am always checking in but only responding if Thomas has not yet taken some responses. I appreciate the concern!
Best regards to you and everyone in the community!
3 Likes
Hi @bob,
Patient frustration in the HBV space is of course very understandable as a lot of excitement and expectation have been created around many technologies in the past 3-4 years which have failed.
Expressing this kind of frustration as a patient is very appropriate on this forum as patient support is one of the key focuses here. In this regard the pharma industry and KOLs who are paid by these organizations bear the responsibility for these frustrations in the patient community.
However, we have to be careful with comments about bias and corruption that we donāt paint these organizations with too broad a brush: many of the people who work for these organizations or individual principle investigators (academic or clinical) are hard working individuals with integrity and a drive to make a difference.
Cheers,
4 Likes
Hi @availlant its been a while we havenāt heard from you. I understand the stress and frustration some people are going throug waiting for cure to come,its difficult sometime but honestly i feel thereās some people working really really hard finding for cure. I am very optimistic with NAPS Replicator that @availlant is working with, just wondering howās the progress.
Thanks.
Dear @12345678,
Thank you for your comments. Developmental progress of NAPs continues to be very successful in our current compassionate use program in patients with HBV / HDV co-infection who have failed to respond to pegIFN or bulevirtide. REP 2139-Mg continues to demonstrate excellent safety and efficacy in patients (including achieving functional cure of HBV and HDV) with very advanced liver disease (cirrhosis and decompensated cirrhosis). These studies are helping to convince everyone in the industry how safe and useful this drug will be in ALL patients with chronic HBV infection, regardless of disease stage or co-infection with other viruses.
You can check out the latest results from our clinical studies at http://replicor.com/press-releases/.
Best regards,
4 Likes
Thank you very much and we (the community) really appreciate you being a responsive expert and at the same time THE main driver of Replicor/REP 2139-M and I have no doubt many of us will be cured when this becomes availableā¦Again Thank you!!
Nas
2 Likes
Hello @availlant
I saw in the upcoming hepatitis conference there is going to be a presentation on NAPs mode of action on some new duck models which previously didnt show any effect of ducks but worked well in humans. Would Replicor use this to establish mode of action to larger community and push the development of NAPs?
I can imagine the concernās people have. Living in the US, having insurance and medical facilities, as well as places to get medication (pharmacy) every 5 minute drive.
Then there are others who live in some parts of the world that just arenāt like that.
We are all in the same boat, but some of us are in the luxury suite and others are in in the hull of the boat. So I can see the frustration. Stay strong, stay healthy.
3 Likes
Hi @Ash_Malhotra,
Since 2013, we have published the antiviral activity of NAPs extensively in the duck model please see here, here, here, here and here. The activity of NAPs in the duck model has always predicted their activity in humans.
I am not sure what conference you are referring to but there are no upcoming Replicor presentations with animal model data. We are presenting updated results from our compassionate access program at EASL next week in Vienna.
Best regards,
2 Likes
@availlant I read one of the oral presentations. Good progress. Could you help shed light on
- 78% of patients maintain immune control / normal liver function off therapy
Up to 56% functional cure at 5.3 years. Question is, has the 56%been changing. To mean at end of one yr the figure was high? If yes why. The time aspect, the 78 and the 56 confuse - Do NAPs deal with the risk of HCC once and for all? and esp for all for those with functional cure as a result of this treatment?